Table II.
Parameter | Baseline visit | Control visit 90 days after PCI | ||||
---|---|---|---|---|---|---|
Group I | Group II | Value of p | Group I | Group II | Value of p | |
LVEDV [ml] | 98.37 ±26.7 | 85.36 ±23.8 | < 0.05 | 107.57 ±36.9 | 87.36 ±22.7 | 0.02 |
LVESV [ml] | 41.56 ±18.5 | 33.20 ±16.0 | 0.05 | 44.83 ±22.16 | 32.44 ±16.9 | 0.02 |
EF (%) | 56.98 ±8.9 | 62.88 ±7.5 | < 0.01 | 58.32 ±8.9 | 64.16 ±6.4 | < 0.01 |
WMSI | 1.16 ±0.2 | 1.02 ±0.1 | < 0.01 | 1.2 ±0.3 | 1.02 ±0.1 | < 0.01 |
sCapex (%) | –22.77 ±10.5 | –26.81 ±10.22 | 0.10 | –22.85 ±9.9 | –29.03 ±8.6 | < 0.01 |
sCbas (%) | –16.91 ±7.2 | –20.46 ±6.7 | 0.04 | –18.50 ±6.4 | –20.88 ±6.3 | 0.12 |
sRapex (%) | 11.89 ±7.0 | 13.79 ±7.8 | 0.27 | 14.15 ±5.5 | 13.02 ±6.6 | 0.09 |
sRbas (%) | 19.00 ±10.3 | 20.85 ±6.9 | 0.40 | 19.86 ±8.1 | 24.16 ±9.7 | 0.04 |
sLa2 (%) | –11.01 ±3.7 | –12.73 ±2.1 | 0.03 | –11.80 ±4.2 | –12.21 ±2.9 | 0.66 |
sLa4 (%) | –11.36 ±4.3 | –12.63 ±2.9 | 0.18 | 12.18 ±4.9 | –14.23 ±3.6 | 0.06 |
sTa2 (%) | 14.02 ±7.5 | 14.03 ±6.5 | 0.99 | 14.28 ±8.2 | 17.87 ±9.1 | 0.08 |
sTa4 (%) | 14.18 ±8.3 | 14.79 ±7.7 | 0.75 | 15.00 ±8.6 | 15.69 ±7.5 | 0.72 |
Rot apex [o] | 6.43 ±3.7 | 5.52 ±3.8 | 0.31 | 5.17 ±3.1 | 7.38 ±3.9 | 0.01 |
Rot bas [o] | –2.83 ±2.1 | –3.78 ±2.6 | 0.08 | –3.58 ±2.6 | –5.22 ±3.5 | 0.02 |
Torsion [o] | 8.74 ±5.0 | 9.38 ±5.5 | 0.73 | 8.22 ±4.3 | 12.24 ±6.1 | < 0.01 |
PCI – percutaneous coronary intervention, LVEDV – left ventricular end diastolic volume, LVESV – left ventricular end systolic volume, EF – ejection fraction, WMSI – wall motion score index, s – strain, C – circumferential, R – radial, L – longitudinal, T – transverse, apex – apical segments, bas – basal segments, a2 – apical 2-chamber view, a4 – apical 4-chamber view, Rot – rotation.